Our data indicate that IDB0076 may also trigger cointernalization of a cognate receptor (VEGFR1 for VEGFB and PlGF2) by inducing cellular internalization of NRP1 and should break the resistance to bevacizumab by blocking these growth factors taking part in tumor angiogenesis. This evidence concerns the gene FLT1 and neoplasm.